Zurück zu Projekte

13760.1;9 PFFLE-LS

Anti-Myelin-Associated Glycoprotein Neuropathy: Development of a New Diagnostic Assay

Zusammenfassung

Anti-Myelin-Associated Glycoprotein Neuropathy: Development of a New Diagnostic Assay

Weitere Texte

Abstract

Anti-myelin-associated glycoprotein (MAG) neuropathy is a peripheral demyelinating neuropathy which is caused by IgM autoantibodies recognizing the carbohydrate epitope of MAG. The aim of this project is to chemically synthesize such epitope structures and to develop a new clinical test based on these MAG mimic epitopes to replace the existing BÜHLMANN anti-MAG ELISA based on a MAG antigen purified from human brains. The synthetic epitopes will also be combined with five different ganglioside epitopes (glycolipid structures) of the existing BÜHLMANN GanglioCombi® assay to generate a novel screening method suited for determining any peripheral neuropathies caused by autoantibodies to nerve structures. The simplified, automated production of microtiter plates and the development and validation of a software interpreting the results of this new Ganglio/MAG screening assay will complete the entire test package.

Beteiligte

Beat Ernst

Kontaktperson

beat.ernst@unibas.ch

Universität Basel Beat Ernst Klingelbergstrasse 50 4056 Basel BS CH

Projektdetails

Forschungsstelle
INNOSUISSE
Projektstatus
Abgeschlossen
Projekttyp
Forschungsprojekt
Startdatum
2011-12-31
Enddatum
2013-12-05
Bewilligte Gesamtkosten
CHF 187000.00
Sektion
5 KTI
NABS Politikbereich
Nicht aufteilbare / nicht zuteilbare Forschung

Forschungsdisziplinen

  • T115 Medical technology 100.0%